No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
TROW T. Rowe Price
- 116.740
- +0.770+0.66%
Trading Jul 23 12:16 ET
26.07BMarket Cap13.86P/E (TTM)
117.020High115.180Low280.26KVolume115.300Open115.970Pre Close32.66MTurnover0.13%Turnover Ratio15.04P/E (Static)223.30MShares122.56752wk High2.66P/B25.47BFloat Cap84.57552wk Low4.90Dividend TTM218.20MShs Float199.510Historical High4.20%Div YieldTTM1.59%Amplitude4.688Historical Low116.534Avg Price1Lot Size
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Decent Equity Market to Aid T. Rowe Price (TROW) in Q2 Earnings
Morgan Stanley Maintains T. Rowe Price(TROW.US) With Hold Rating, Maintains Target Price $125
Express News | T Rowe Price Group Inc : JP Morgan Raises Target Price to $107 From $102
The Best U.S. City for Retirement Healthcare
Tesla, AT&T, Alphabet, Chipotle, Visa, and More Stocks to Watch This Week
Little Excitement Around T. Rowe Price Group, Inc.'s (NASDAQ:TROW) Earnings
Comments
Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.
$Datadog(DDOG.US$: “I want to see what Salesforce reports tomorrow, because Workday was not as good as I’d like. If Salesforce is not as good as I’d like, then Datadog’s going to go down. Let’s hold off for a day.”
$Axcelis Technologies(ACLS.US$ : “That company is a very good semiconductor that’s been left behind. I find that very ...
$Datadog(DDOG.US$: “I want to see what Salesforce reports tomorrow, because Workday was not as good as I’d like. If Salesforce is not as good as I’d like, then Datadog’s going to go down. Let’s hold off for a day.”
$Axcelis Technologies(ACLS.US$ : “That company is a very good semiconductor that’s been left behind. I find that very ...
6
OHA and TPO's partnership is strategic for STV's growth, focusing on geographic and service line expansion. OHA's industry experience and financing solutions are highly valued.
1
OHA believes that Greenway Health is well-positioned for scalable and profitable growth. The firm also expects the financing opportunity to continue to grow in 2024 for high-quality borrowers to address near-term maturities.
1
Despite the slump in earnings, T. Rowe Price's P/E ratio hints at hopeful investors, contrasting analysts' pessimism. The ongoing decline in earnings may affect future share price.
CEO Rob Sharps commends Eric Veiel's promotion, acknowledging his innovative thinking, commitment to high-standard investments, diversity and global perspective.
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
